Follow
Elena Ramírez
Elena Ramírez
Alumna pedagogía, Universidad de Murcia
No verified email - Homepage
Title
Cited by
Cited by
Year
A cohort of patients with COVID-19 in a major teaching hospital in Europe
AM Borobia, AJ Carcas, F Arnalich, R Álvarez-Sala, J Monserrat-Villatoro, ...
Journal of clinical medicine 9 (6), 1733, 2020
3282020
Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches
C Gonzalez-Herrada, S Rodriguez-Martin, L Cachafeiro, V Lerma, ...
Journal of Investigative Dermatology 137 (10), 2092-2100, 2017
1382017
Overuse of PPIs in patients at admission, during hospitalisation, and at discharge in a terciary Spanish hospital
E Ramirez, S H Lei, A M Borobia, E Pinana, S Fudio, R Muñoz, A Campos, ...
Current clinical pharmacology 5 (4), 288-297, 2010
1162010
Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome
R Cabañas, E Ramírez, E Sendagorta, R Alamar, R Barranco, ...
J Investig Allergol Clin Immunol 30 (4), 229-253, 2020
1062020
Concentrations of organochlorine pesticides and polychlorinated biphenyls in human serum and adipose tissue from Bolivia
JP Arrebola, M Cuellar, E Claure, M Quevedo, SR Antelo, E Mutch, ...
Environmental research 112, 40-47, 2012
1062012
Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System
E Ramirez, O Laosa, P Guerra, B Duque, B Mosquera, AM Borobia, ...
British journal of clinical pharmacology 70 (5), 694-702, 2010
972010
Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection
AM Borobia, I Romero, C Jimenez, F Gil, E Ramirez, R De Gracia, ...
Therapeutic drug monitoring 31 (4), 436-442, 2009
952009
A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients
E Ramirez, AJ Carcas, AM Borobia, SH Lei, E Piñana, S Fudio, J Frias
Clinical Pharmacology & Therapeutics 87 (1), 74-86, 2010
852010
An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease
AM Borobia, R Lubomirov, E Ramírez, A Lorenzo, A Campos, ...
PloS one 7 (7), e41360, 2012
812012
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ...
The Lancet infectious diseases 21 (6), 783-792, 2021
772021
Effectiveness and limitations of an incident-reporting system analyzed by local clinical safety leaders in a tertiary hospital: Prospective evaluation through real-time …
E Ramírez, A Martín, Y Villán, M Lorente, J Ojeda, M Moro, C Vara, ...
Medicine 97 (38), e12509, 2018
752018
Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment
R Cabañas, O Calderón, E Ramírez, A Fiandor, T Caballero, R Heredia, ...
Clinical & Experimental Allergy 48 (3), 325-333, 2018
712018
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish …
E Ramírez, T Bellón, HY Tong, AM Borobia, FJ de Abajo, V Lerma, ...
Pharmacological research 115, 168-178, 2017
712017
Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: results from a retrospective cohort study
E Ramírez, JA Romero-Garrido, E López-Granados, AM Borobia, T Pérez, ...
Thrombosis research 133 (6), 1045-1051, 2014
682014
Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients
R Cabañas, O Calderon, E Ramirez, A Fiandor, N Prior, T Caballero, ...
J Investig Allergol Clin Immunol 24 (6), 425-430, 2014
672014
Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram
S Fudio, AM Borobia, E Piñana, E Ramírez, B Tabarés, P Guerra, ...
European journal of pharmacology 626 (2-3), 200-204, 2010
642010
Clinical implementation of pharmacogenetic testing in a hospital of the Spanish National Health System: strategy and experience over 3 years
AM Borobia, I Dapia, HY Tong, P Arias, M Muñoz, J Tenorio, R Hernández, ...
Clinical and translational science 11 (2), 189-199, 2018
462018
Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case‐control in a retrospective cohort study
E Ramirez, R Cabanas, LS Laserna, A Fiandor, H Tong, N Prior, ...
Clinical & Experimental Allergy 43 (3), 344-352, 2013
452013
DRESS‐syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11‐year‐old Caucasian boy
E Piñana, SH Lei, R Merino, M Melgosa, R De La Vega, ...
Journal of clinical pharmacy and therapeutics 35 (3), 365-370, 2010
412010
Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital
E Ramírez, N Medrano‐Casique, HY Tong, T Bellón, R Cabañas, ...
British Journal of Clinical Pharmacology 83 (2), 400-415, 2017
352017
The system can't perform the operation now. Try again later.
Articles 1–20